Macromolecular IgA1 taken from patients with familial IgA Nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro

Kidney International

Volumn 75, Issue 12, 2009, Pages 1330-1339

  Tam, Ka Ying ^a   Leung, Joseph C K ^a   Chan, Loretta Y Y ^a   Lam, Man Fai ^a   Tang, Sydney C W ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytokines; Galactose deficiency; Human mesangial cells; IgA nephropathy; Macromolecular IgA1; Multiplex IgAN family

Indexed keywords

GALACTOSE; IMMUNOGLOBULIN A1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION;

BASE SEQUENCE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CCL2; DNA PRIMERS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MESANGIAL CELLS; MULTIPROTEIN COMPLEXES; PROGNOSIS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349139414     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.71     Document Type: Article

References (48)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727.
2. Pouria S, Barratt J. Secondary IgA nephropathy. Semin Nephrol 2008; 28: 27-37.
3. Novak J, Julian BA, Tomana M et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 2008; 28: 78-87.
4. Egido J, Garcia-Hoyo R, Lozano L et al. Immunological studies in familial and sporadic IgA nephropathy. Semin Nephrol 1987; 7: 311-314.
5. Wakai K, Kawamura T, Matsuo S et al. Risk factors for IgA nephropathy: a case-control study in Japan. Am J Kidney Dis 1999; 33: 738-745.
6. Hsu SI, Ramirez SB, Winn MP et al. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000; 57: 1818-1835.
7. Izzi C, Sanna-Cherchi S, Prati E et al. Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 2006; 69: 1033-1040.
8. Beerman I, Novak J, Wyatt RJ et al. The genetics of IgA nephropathy. Nat Clin Pract Nephrol 2007; 3: 325-338.
9. Frimat L, Kessler M. Controversies concerning the importance of genetic polymorphism in IgA nephropathy. Nephrol Dial Transplant 2002; 17: 542-545.
10. Hsu SI. Racial and genetic factors in IgA nephropathy. Semin Nephrol 2008; 28: 48-57.
11. Schena FP, Cerullo G, Rossini M et al. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 2002; 13: 453-460.
12. Gharavi AG, Moldoveanu Z, Wyatt RJ et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1008-1014.
13. Tolkoff-Rubin NE, Cosimi AB, Fuller T et al. IGA nephropathy in HLA-identical siblings. Tr ansplantation 1978; 26: 430-433.
14. Sabatier JC, Genin C, Assenat H et al. Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 1979; 11: 35-38.
15. Levy M. Familial cases of Berger's disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 1989; 87: 246-248.
16. Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol 2008; 28: 1-7.
17. Li PK, Burns AP, So AK et al. Familial IgA nephropathy: a study of HLA class II allogenotypes in a Chinese kindred. Am J Kidney Dis 1992; 20: 458-462.
18. Li YJ, Du Y, Li CX et al. Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3′ untranslated region of the Megsin gene. J Am Soc Nephrol 2004; 15: 1739-1743.
19. Izzi C, Ravani P, Torres D et al. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression. Am J Kidney Dis 2006; 47: 761-769.
20. Julian BA, Woodford SY, Baehler RW et al. Familial clustering and immunogenetic aspects of IgA nephropathy. Am J Kidney Dis 1988; 12: 366-370.
21. Geddes CC, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-1548.
22. Mestecky J, Tomana M, Moldoveanu Z et al. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press Res 2008; 31: 29-37.
23. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509-516.
24. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-973.
25. Novak J, Vu HL, Novak L et al. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 2002; 62: 465-475.
26. Leung JC, Chan LY, Tang SC et al. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy. Nephron Exp Nephrol 2007; 107: e107-e118.
27. Leung JC, Tsang AW, Chan LY et al. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. J Lab Clin Med 2002; 140: 398-406.
28. Czerkinsky C, Koopman WJ, Jackson S et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 1986; 77: 1931-1938.
29. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504-513.
30. Moura IC, Arcos-Fajardo M, Sadaka C et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004; 15: 622-634.
31. Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 1997; 159: 3474-3482.
32. Lai KN, Tang SC, Guh JY et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 2003; 14: 3127-3137.
33. Leung JC, Tang SC, Chan LY et al. Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA -role of MAPK and NF-kappaB. Nephrol Dial Transplant 2008; 23: 72-81.
34. Karkar AM, Smith J, Pusey CD. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha. Nephrol Dial Transplant 2001; 16: 518-524.
35. Chan LY, Leung JC, Tsang AW et al. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int 2005; 67: 602-612.
36. Lai KN, Leung JC, Chan LY et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 2009; 24: 62-72.
37. Shu KH, Lee SH, Cheng CH et al. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-789.
38. Horii Y, Iwano M, Hirata E et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int Suppl 1993; 39: S71-S75.
39. Lim CS, Zheng S, Kim YS et al. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 2001; 16: 269-275.
40. Stahl RA, Thaiss F, Disser M et al. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1993; 44: 1036-1047.
41. Biswas P, Delfanti F, Bernasconi S et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998; 91: 258-265.
42. Coletta I, Soldo L, Polentarutti N et al. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Exp Nephrol 2000; 8: 37-43.
43. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11: 97-101.
44. Taniguchi Y, Yorioka N, Oda H et al. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study. Nephron 1996; 74: 652-660.
45. Lai KN, Ho CP, Chan KW et al. Nephrotic range proteinuria-a good predictive index of disease in IgA nephropathy? Q J Med 1985; 57: 677-688.
46. To WY, Leung JC, Lai KN. Identification and characterization of human serum alpha2-HS glycoprotein as a jacalin-bound protein. Biochim Biophys Acta 1995; 1249: 58-64.
47. Lai KN, To WY, Li PK et al. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int 1996; 49: 839-845.
48. Leung JC, Chan LY, Tam KY et al. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 458-469.